Product Information
Biopharmaceutical Analysis
Biopharmaceutical Analysis
From mAbs to Oligos, We Have You Covered

Phenomenex is committed to the development of novel chromatographic solutions that advance biopharmaceutical development. This rapidly-growing industry necessitates fit for purpose applications and innovative technologies to meet the expanding analytical challenges of the field.

Phenomenex columns and sample preparation solutions are designed to tackle the multi-faceted analytical needs of large molecule analysis:

  • Aggregate Analysis
  • Drug Antibody Ratio (DAR)
  • Glycan Analysis
  • Intact Mass
  • Intact mAbs and Subunit Analysis
  • Immunocapture (MagBeads)
  • Peptide Mapping
  • Peptide Quantitation
  • Charge Variant Analysis (IEX)
  • Oligonucleotide Characterization
  • Glycan Sample Prep (SPE)

Latest Resources

bioZen WidePore C4 Intact mAbs and Subunit Analysis
bioZen Oligo LC Column Oligonucleotide Characterization and Quantitation
bioZen MagBeads Streptavidin Coated Paramagnetic Beads
Top Tips!

Check out our most commonly asked Biopharmaceutical Analysis Questions.

What is the loading capacity of bioZen Peptide and Intact columns?

The bioZen Peptide columns have similar loading capacities as reversed phase HPLC/UHPLC columns. A 5-20 μg of digest or peptide mixture on a 4.6 mm ID column will provide good sensitivity especially for LC-MS peptide separations. Up to 50 μg of digest can be loaded without increasing peak width too severely. For 2.1 mm ID columns, loading should be scaled accordingly. For bioZen Intact columns, overloading can drastically affect peak shape due to their lower surface area and must be determined experimentally for optimal results. For 4.6 mm ID’s, 5 μg is a good starting point. For 2.1 mm ID’s, 1 μg is a recommended starting point. Increasing in load may increase peak tailing and peak width significantly.

What are some mobile phase considerations for Size Exclusion Chromatography/GFC?

The most common application for SEC is aggregate analysis, which requires “native” conditions (i.e. physiological conditions). These conditions require a buffered solution at around pH 7 with a moderate amount of salt. A good starting point for mobile phase is a 100 mM Phosphate Buffer, pH 6.8. However, there are some instances where it is appropriate to optimize the mobile phase to improve chromatography. If you suspect that the protein is hydrophobic, a small amount of organic solvent (e.g. methanol, acetonitrile, or isopropanol) can be added generally anywhere between 5-10 %. If you suspect that the protein may have strong ionic characteristics (e.g. basic protein or protein with a high isoelectric point), the ionic strength of the eluent can be increased to improve chromatography. A 2x phosphate buffered saline (i.e. 50 mM phosphate, 300 mM sodium chloride, pH 6.8) is recommended to prevent secondary interactions. Note that increasing the salt will also increase hydrophobic interactions. Further, varying the salt may improve the separation of one critical pair, but result in a loss of resolution of another.

Visit Our Guru

We’re traveling the globe to meet our customers, come visit us!  

TIDES Europe: Oligonucleotide and Peptide Therapeutics – 2-5 November 2021
Featured Products

bioZen HPLC
bioZen HPLC/UHPLC Columns with titanium biocompatible hardware to minimize priming, three particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity.


bioZen SPE
Solid phase extraction (SPE) HILIC stationary phase provide streamlined clean-up and Streptavidin Coated MagBeads are ideal for isolating proteins and peptides in less time with a high response.


Clarity BioSolutions
Purify and characterize synthetic oligonucleotides used in biological research, therapeutic development and biochemical manufacturing.